| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2008 | US7364887 Osteoarthritis; rheumatic diseases; antiarthritic agents |
| 04/29/2008 | US7364868 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders |
| 04/29/2008 | US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364845 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 04/29/2008 | US7364743 Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
| 04/29/2008 | US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions |
| 04/29/2008 | US7364737 Binding, neutralization respiratory syncytial virus antigen |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364732 Method for treating inflammation |
| 04/29/2008 | US7364731 Polypeptide variants |
| 04/29/2008 | US7364730 Human K+ channel and prognosing applications thereof |
| 04/29/2008 | US7364729 Method of inducing a CTL response |
| 04/29/2008 | US7364725 Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | US7364722 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 04/29/2008 | US7364719 Vasoregulating compounds and methods of their use |
| 04/29/2008 | US7364565 Controlled enzymatic removal and retrieval of cells |
| 04/29/2008 | CA2567582C Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates |
| 04/29/2008 | CA2416492C Treatment of glycogen storage disease type ii |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2351341C Collagen hemostatic foam |
| 04/29/2008 | CA2337667C Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2316159C Prolonged release microcapsules |
| 04/29/2008 | CA2304712C Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 04/29/2008 | CA2294756C Cross-linked polysaccharide drug carrier |
| 04/29/2008 | CA2266416C Insulin c-peptides |
| 04/29/2008 | CA2244078C Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents |
| 04/29/2008 | CA2230372C Quantitation of p97 to diagnose and monitor alzheimer's disease |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/24/2008 | WO2008049073A2 Compositions for the treatment of inflammation in the brain and other tissues |
| 04/24/2008 | WO2008049058A2 Cln2 treatment of alzheimer's disease |
| 04/24/2008 | WO2008049056A2 Treatment of medical condition with a2 domain of von willebrand factor |
| 04/24/2008 | WO2008049043A2 Ophthalmic compositions comprising diglycine |
| 04/24/2008 | WO2008049011A2 Alpha-msh therapies for treatment of autoimmune disease |
| 04/24/2008 | WO2008048784A1 Pegylated pth as pth receptor modulators and uses thereof |
| 04/24/2008 | WO2008048675A2 Treatment for age-related macular degeneration and other diseases of the eye |
| 04/24/2008 | WO2008048574A2 Hca for improved hdl serum lipids profile |
| 04/24/2008 | WO2008048560A2 Toll-like receptor agonist regulation of vegf-induced tissue responses |
| 04/24/2008 | WO2008048466A2 Bone resorption disorders |
| 04/24/2008 | WO2008048373A2 Compounds and methods for modulating protein degradation |
| 04/24/2008 | WO2008048306A2 Influenza a virus vaccines and inhibitors |
| 04/24/2008 | WO2008048298A2 Polymer particles for delivery of macromolecules and methods of use |
| 04/24/2008 | WO2008048134A1 Pharmaceutical compositions for preventing and treating eye pathologies |
| 04/24/2008 | WO2008048057A1 Myonectin and uses thereof |
| 04/24/2008 | WO2008047904A1 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/24/2008 | WO2008047792A1 Crystal of glutathione and process for production thereof |
| 04/24/2008 | WO2008047473A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| 04/24/2008 | WO2008047364A2 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 04/24/2008 | WO2008047241A2 Modified corticotropin releasing factor peptides and uses thereof |
| 04/24/2008 | WO2008046909A1 The histone deacetylase inhibitor helminthosporium carbonum toxin for suppressing malignant qualities of neuroblastoma cells |
| 04/24/2008 | WO2008046860A2 Bioavailable combinations for hcv treatment |
| 04/24/2008 | WO2008046650A1 Novel method for treating h.pylori infections |
| 04/24/2008 | WO2008046649A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 04/24/2008 | WO2008046256A1 Haemocoagulase |
| 04/24/2008 | WO2008046251A1 Fusion proteins containing n domain of human calreticulin and human papillomavirus type 16 e6 or e7 and uses thereof |
| 04/24/2008 | WO2008046228A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same |
| 04/24/2008 | WO2008009711A3 Use of soluble cd160 to suppress immunity |
| 04/24/2008 | WO2008009638A3 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/24/2008 | WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/24/2008 | WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 04/24/2008 | WO2007132355A3 Compositions and methods for inhibiting viral adhesion |
| 04/24/2008 | WO2007121125A3 Hcv inhibitors |
| 04/24/2008 | WO2007112703A3 Pharmaceutical composition containing the nmb0606 protein |
| 04/24/2008 | WO2007104946A3 Medicaments and proteins based on tgf-beta monomers for the treatment of wounds |
| 04/24/2008 | WO2007095350A3 Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments |
| 04/24/2008 | WO2007081654A3 Compositions and methods to enhance viability and function of islet cells |
| 04/24/2008 | WO2007012033A3 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 04/24/2008 | WO2007011874A3 Formulation and method for administration of ophthalmologically active agents |
| 04/24/2008 | WO2006079099A3 Method of conjugating aminothiol containing molecules to a polymer |
| 04/24/2008 | WO2002036740A8 Apoptosis-inducing ribozymes |
| 04/24/2008 | US20080097278 Treatment of Skin with Light and a Benefit Agent |
| 04/24/2008 | US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080097081 BH3 interacting domain death agonist for use in prevention ans treatment of apoptosis associated disorders |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096948 Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation |
| 04/24/2008 | US20080096865 Improved photodynamic treatment against subfoveal choroidal neovascularization; administering midostaurin, vatalanib dihydrochloride or octreotide with a photosensitive porphyrin or purpurin; angiogenesis inhibition |
| 04/24/2008 | US20080096840 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents |
| 04/24/2008 | US20080096835 Inhibitory oligonucleotides targeted to BCL-2 |
| 04/24/2008 | US20080096834 Administering a nucleic acid encoding a trout E-domain peptide or somatomedin as antiproliferative, anticarcinogenic and/or antitumor agent in mammals or fish |
| 04/24/2008 | US20080096832 non-nucleoside HIV-1 reverse transcriptase inhibitor (NNRTI); co-administering cytochrome P450 inhibitor such as ritonavir to reduce metabolism of the NNRTI 5,11-Dihydro-11-ethyl-5-methyl-8- {2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one, (BILR 355 ) by half |
| 04/24/2008 | US20080096824 administering oligopeptides to prevent apoptosis in stroke, heart attack or ischemia patients and patients having degenerative diseases, infection caused by bacteria, viruses or protozoa, and reduce side effects of chemotherapy and radiotherapy |
| 04/24/2008 | US20080096823 Neurotensin receptor agonists and opioid receptor agonists |
| 04/24/2008 | US20080096822 Use of the Neurotoxic Component of a Botulinum Toxin |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096819 Amino acid substituted molecules |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096817 administering actin-sequestering peptides, for the treatment, prevention of injury or inflammation of eyes due to surgery or dryness |
| 04/24/2008 | US20080096816 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096815 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096814 Orally administered peptides synergize statin activity |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents |